Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université du Québec à Montréal

$30,000.00

Self-assembling macromolecular materials for pharmaceutical and biomedical applications

EF 2012-13

Résumé
Self-assembling macromolecular materials for pharmaceutical and biomedical applications Years ago, with a graduate student and two colleagues from U de Montreal, we have introduced the Cross-Linked High Amylose Starch (CL-HAS) as novel pharmaceutical excipient. Surprisingly, major differences were observed for minor increases of cld. The CL-HAS at low cld was found as an excipient for controlled drug release over 24 h, whereas CL-HAS at slightly higher cld was found as a binder and fast disintegrant. Inter-chain self-stabilisation via hydrogen association can coexist with cross-linking, only at a low cld (ensuring enough chains flexibility to allow hydrogen bonding). This stabilisation cannot occur at higher cld, where hydroxylic groups are free to hydrate rapidly, with very fast disintegration. This was a good model to show that for complex macromolecules, minor modifications can generate major improvements, due to self-assembling capacities of obtained materials. This research program consists in investigation of parameters that will allow best ability of polymeric systems to organize them-selves such as to afford desired qualities of materials for pharmaceutical and biomedical purposes. We are now proposing Carboxymethyl (CM)-Starch as matrix for oral drug delivery based on Hydrogen association and on ionic self-stabilisation via CM groups. When CM-Starch tablet will reach the intestinal fluid, the proton is changed for sodium, triggering hydration, matrix dissolution and drug delivery. The objective of this research will be to realise tablets and microspheres for oral delivery of drugs with various adsorption sites, of vaccines (via mucosal immunity) or of bioactive agents for colon diseases. A composite systems based on ionic self-stabilization of carboxylated CM-HAS and amino (Chitosan) was proposed to deliver probiotics (ex. L. rhamnosus) to colon. Polyvinylalcohol (PVA) presents an interesting ability to organize itself in films. We will exploit this capacity, improving the associative characteristics by adequate modifications in order to obtain vascular xenografts.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
386421-2010
Name nom
Mateescu, MirceaAlexandru
Department département
Chimie
Organization id
57
Institution établissement
Université du Québec à Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2010
Award amount
30000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
3
Nb partie
5
Application title
Self-assembling macromolecular materials for pharmaceutical and biomedical applications
Keyword
NSERC
Application summary
Self-assembling macromolecular materials for pharmaceutical and biomedical applications Years ago, with a graduate student and two colleagues from U de Montreal, we have introduced the Cross-Linked High Amylose Starch (CL-HAS) as novel pharmaceutical excipient. Surprisingly, major differences were observed for minor increases of cld. The CL-HAS at low cld was found as an excipient for controlled drug release over 24 h, whereas CL-HAS at slightly higher cld was found as a binder and fast disintegrant. Inter-chain self-stabilisation via hydrogen association can coexist with cross-linking, only at a low cld (ensuring enough chains flexibility to allow hydrogen bonding). This stabilisation cannot occur at higher cld, where hydroxylic groups are free to hydrate rapidly, with very fast disintegration. This was a good model to show that for complex macromolecules, minor modifications can generate major improvements, due to self-assembling capacities of obtained materials. This research program consists in investigation of parameters that will allow best ability of polymeric systems to organize them-selves such as to afford desired qualities of materials for pharmaceutical and biomedical purposes. We are now proposing Carboxymethyl (CM)-Starch as matrix for oral drug delivery based on Hydrogen association and on ionic self-stabilisation via CM groups. When CM-Starch tablet will reach the intestinal fluid, the proton is changed for sodium, triggering hydration, matrix dissolution and drug delivery. The objective of this research will be to realise tablets and microspheres for oral delivery of drugs with various adsorption sites, of vaccines (via mucosal immunity) or of bioactive agents for colon diseases. A composite systems based on ionic self-stabilization of carboxylated CM-HAS and amino (Chitosan) was proposed to deliver probiotics (ex. L. rhamnosus) to colon. Polyvinylalcohol (PVA) presents an interesting ability to organize itself in films. We will exploit this capacity, improving the associative characteristics by adequate modifications in order to obtain vascular xenografts.